BSE Live
Oct 10, 16:01Prev. Close
1763.10
Open Price
1702.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:49Prev. Close
1760.20
Open Price
1740.10
Bid Price (Qty.)
1741.80 (3)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Hester Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | |
Total Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | |
Reserves and Surplus | 330.58 | 304.21 | 283.88 | 259.93 | 229.07 | |
Total Reserves and Surplus | 330.58 | 304.21 | 283.88 | 259.93 | 229.07 | |
Total Shareholders Funds | 339.09 | 312.71 | 292.38 | 268.43 | 237.58 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 51.31 | 79.07 | 83.40 | 73.25 | 2.68 | |
Deferred Tax Liabilities [Net] | 5.73 | 7.09 | 7.15 | 6.29 | 6.81 | |
Other Long Term Liabilities | 50.78 | 50.70 | 24.70 | 0.55 | 0.30 | |
Long Term Provisions | 2.38 | 2.26 | 1.72 | 1.08 | 0.00 | |
Total Non-Current Liabilities | 110.21 | 139.11 | 116.96 | 81.17 | 9.79 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 52.96 | 54.49 | 80.93 | 48.66 | 1.71 | |
Trade Payables | 32.53 | 30.12 | 28.71 | 11.03 | 14.03 | |
Other Current Liabilities | 10.29 | 12.44 | 26.39 | 14.91 | 18.05 | |
Short Term Provisions | 0.92 | 0.67 | 0.44 | 0.24 | 0.87 | |
Total Current Liabilities | 96.70 | 97.72 | 136.47 | 74.84 | 34.65 | |
Total Capital And Liabilities | 546.00 | 549.55 | 545.82 | 424.44 | 282.02 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 104.83 | 102.89 | 107.85 | 83.95 | 86.31 | |
Intangible Assets | 0.63 | 0.57 | 0.37 | 0.36 | 0.33 | |
Capital Work-In-Progress | 176.67 | 168.11 | 146.14 | 80.22 | 3.54 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | |
Fixed Assets | 288.16 | 274.86 | 256.82 | 166.22 | 90.23 | |
Non-Current Investments | 64.69 | 64.69 | 64.69 | 64.69 | 43.89 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | |
Other Non-Current Assets | 7.91 | 5.59 | 8.25 | 27.06 | 7.55 | |
Total Non-Current Assets | 360.76 | 345.13 | 329.77 | 257.97 | 142.41 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 58.51 | 68.53 | 79.22 | 70.73 | 57.01 | |
Trade Receivables | 80.60 | 85.78 | 82.36 | 56.92 | 45.55 | |
Cash And Cash Equivalents | 2.18 | 4.96 | 5.96 | 1.98 | 1.24 | |
Short Term Loans And Advances | 5.70 | 5.69 | 5.85 | 5.88 | 18.00 | |
OtherCurrentAssets | 38.26 | 39.46 | 42.66 | 30.97 | 17.80 | |
Total Current Assets | 185.24 | 204.41 | 216.05 | 166.47 | 139.61 | |
Total Assets | 546.00 | 549.55 | 545.82 | 424.44 | 282.02 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 236.78 | 260.34 | 260.76 | 276.50 | 104.93 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 2.71 | 2.16 | 3.88 | 13.72 | 2.10 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 22.03 | 39.01 | 30.88 | 23.01 | 35.66 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 2.84 | 2.84 | 2.84 | 2.84 | 2.84 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 64.69 | 64.69 | 64.69 | 64.69 | 43.89 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
09.05.2025
Hester Bio Consolidated March 2025 Net Sales at Rs 81.93 crore, up 3.37% Y-o-Y
31.01.2025
Hester Bio Consolidated December 2024 Net Sales at Rs 63.22 crore, down 5.62% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
09.05.2025
Hester Bio Consolidated March 2025 Net Sales at Rs 81.93 crore, up 3.37% Y-o-Y
31.01.2025
Hester Bio Consolidated December 2024 Net Sales at Rs 63.22 crore, down 5.62% Y-o-Y